The serum fatty acids myristic acid and linoleic acid are better predictors of serum cholesterol concentrations when measured as molecular percentages rather than as absolute concentrations [1] [2] [3] Kathryn E Bradbury, C Murray Skeaff, Timothy J Green, Andrew R Gray, and Francesca L Crowe ABSTRACT Background: The use of serum fatty acid biomarkers in nutritional epidemiology is increasingly common; however, there is an absence of scientific evidence to substantiate whether the measurement of fatty acids as molecular percentages (which is the conventional approach) or as absolute concentrations is more informative. Objective: To advance understanding about this fundamental concept, we examined the ability of serum myristic acid and linoleic acid, expressed as molecular percentages or as concentrations, to predict dietary fat and serum cholesterol concentrations. Design: A cross-sectional analysis of a population-based survey of New Zealand adults (n = 2732) was undertaken. The association of myristic and linoleic acids in serum cholesterol ester and phospholipid with dietary fat or serum cholesterol was assessed. Results: Intake of saturated fat, dairy fat, and polyunsaturated fat was predicted similarly with the use of both units of measurement. After adjustment for confounders, mean total cholesterol decreased by 0.18 mmol/L from the lowest to the highest quintile of serum cholesteryl-linoleate as a molecular percentage (P = 0.027). In contrast, mean total cholesterol increased by 1.09 mmol/L from the lowest to the highest quintile of serum cholesteryl-linoleate concentration (P , 0.001). The molecular percentage and concentration of serum cholesteryl-myristate were positively associated with total cholesterol (P , 0.001). Results for serum phospholipid fatty acids were similar. Conclusion: Serum myristic acid and linoleic acid measured as molecular percentages, but not as concentrations, predict serum total cholesterol in a manner that distinguishes between the differential cholesterolemic effects of dietary saturated and polyunsaturated fats.
INTRODUCTION
Serum fatty acid biological markers provide epidemiologists with an additional tool with which to examine the relation between dietary fat and disease risk or disease risk factors, inasmuch as biomarkers reflect actual, rather than reported, intake of fat and are closer to the biological sites of action (1) (2) (3) . A number of serum fatty acids are valid biomarkers of dietary fat; for example, serum linoleic acid reflects dietary polyunsaturated fat intake, the majority of which is normally linoleic acid (1, 4) . Serum myristic acid reflects saturated and dairy fat intake (5) (6) (7) (8) ; however, the strength of the association tends to be weaker than that of serum linoleic acid with dietary polyunsaturates (1) . This arises because, unlike serum linoleic acid, which is only dietary in origin, serum saturated fatty acids (with the exclusion of odd chain lengths) can also be synthesized endogenously (9) .
When serum fatty acids are analyzed, the results can be reported in different units of measurement; each fatty acid can be expressed as an absolute concentration or as a percentage of total fatty acids (ie, molecular percentage). In practice, the latter unit of measurement is by far the most commonly reported; however, this preference appears to be based on convention and precedent because there is little to substantiate that one unit or the other performs better as a predictor of disease risk or disease risk factors. Recent letters to the editor by Chow (10) and Crowe (11) , which concern the most appropriate unit of serum fatty acid measurement to predict prostate cancer risk, exemplifies the uncertainty about the matter. Given the increasingly common application of fatty acid biomarkers in nutritional epidemiology, it is critical to generate scientific evidence that will advance understanding about which unit of measurement is more informative.
Serum cholesterol concentrations are responsive to changes in the type of fat in the diet (12, 13) . In particular, dietary linoleic acid decreases total cholesterol concentrations, whereas dietary myristic acid has the opposite effect (14) . We have shown previously that serum linoleic acid and myristic acid, measured as molecular percentages, predict serum total cholesterol concentrations in a manner that is consistent with the differential cholesterolemic effects of these dietary fatty acids (15) . In that study, which included participants in a national nutrition survey of New Zealanders, the molecular percentage of serum linoleic acid, which is a marker of dietary polyunsaturated fat, was inversely associated with serum total cholesterol, whereas the molecular percentage of serum myristic acid, which is a marker of dietary saturated and dairy fat, was positively associated with total cholesterol. In this article we examine the ability of these 2 fatty acids, expressed as molecular percentages or as concentrations, to predict dietary fat intake and serum cholesterol concentrations in a population-based survey of New Zealand adults.
SUBJECTS AND METHODS

Survey methods
The New Zealand 1997 National Nutrition Survey (NNS97) methodology has been described in detail elsewhere (16, 17) . Briefly, ethical approval for the study was obtained from the 14 ethics committees throughout New Zealand, and all participants (or the guardians of those aged ,18 y) gave informed written consent. The NNS97 sample was drawn from the 1996/1997 New Zealand Health Survey, a population survey that included 7862 New Zealanders aged 15 y, who were randomly selected from a 3-stage stratified sampling design. First, a set of areabased primary sampling units was selected; second, households within these primary sampling units were selected; and finally, a respondent within each household was randomly chosen. Interviews for the New Zealand Health Survey began in October 1996. During a home visit, height and weight were measured and body mass index (BMI; in kg/m 2 ) was calculated. Ethnicity and smoking status were self-reported; participants were categorized as New Zealand Maori, Pacific People (also known as Pacific Islanders), or New Zealand European and other, and as either nonsmokers (which included former smokers) or current smokers. Also during the home visit, participants were asked to undertake a computer-assisted 24-h dietary recall (n = 4636) and to provide a blood sample (n = 3223). Participants were not required to fast before the blood sample, which was taken from an antecubital vein into vacuum evacuated tubes with no anticoagulant. The tubes were centrifuged, and aliquots of the serum were stored in cryovials at 280°C.
Laboratory analysis
Serum total cholesterol concentrations were measured by enzymatic kit (CHOD-PAP method) from Boehringer-Mannheim (now Roche Diagnostics, Basel, Switzerland) on a Hitachi 717 autoanalyzer. HDL cholesterol was measured with the use of a homogenous assay from Boehringer-Mannheim. The accuracy and precision of the total and HDL-cholesterol assays were monitored in accordance with the Royal Australasian College of Pathologists Quality Assurance Program. The CVs for the total and HDL-cholesterol assays were 2.6% and 5.8%, respectively (18) .
An internal standard that contained cholesterol ester and phosphatidylcholine was added to each serum sample (400 lL) before the extraction of lipid in accordance with the method of Bligh and Dyer (19) . Thin-layer chromatography was used to separate out lipid classes with the use of silica gel-coated glass plates in a solvent system that contained hexane:diethyl ether: acetic acid, in the ratio 85:15:1 by volume. Fatty acid methyl esters from the lipid classes cholesterol ester and phospholipid were generated with the use of acid catalyzed methanolysis, with incubation at 80°C in 6% sulfuric acid in methanol for 2 h for cholesterol ester and for 12-16 h for phospholipid. Fatty acid methyl esters were separated with the use of gas liquid chromatography and detected by flame ionization with a DB-225 megabore column (internal diameter: 30 m · 0.25 mm; film thickness: 0.25 lm; J & W Scientific, Deerfield, IL). Throughout the analysis, precision was monitored by the analysis of 1 pooled serum sample for every 20 samples. Serum fatty acids were recorded as concentrations (lmol/L) and as molecular percentages, defined as the number of molecules of the individual fatty acid as a percentage of the total number of fatty acid molecules. Expressed as molecular percentages, the CVs for serum myristic acid were 15.0% (cholesterol ester) and 22.7% (phospholipid) and for linoleic acid they were 3.0% (cholesterol ester) and 10.6% (phospholipid). The CVs for serum myristic acid concentration were 28.7% (cholesterol ester) and 31.6% (phospholipid); for linoleic acid concentration the CVs were 23.9% (cholesterol ester) and 21.6% (phospholipid).
Statistical analysis
Stata statistical software, release 9 (StataCorp LP; College Station, TX), was used for all statistical analyses. To take into account the specific survey design of the NNS97, survey analysis, which included inverse-probability-of-sampling weights, was used where appropriate. For serum myristic acid and linoleic acid, expressed as both molecular percentages and as concentrations in cholesterol ester and phospholipid, z scores were generated by subtracting the unadjusted mean from each value and dividing by the unadjusted SD. Fatty acid z scores , 24 or .4 were excluded from all analyses.
Linear regression was used to examine the association of serum myristic acid and linoleic acid (expressed as both molecular percentages and as concentrations) with saturated fat intake, dairy fat intake, polyunsaturated fat intake, serum total cholesterol, HDL cholesterol, and the ratio of total to HDL cholesterol. For the unadjusted dietary analysis, the quintiles of serum myristic acid and linoleic acid were regressed as categorical variables onto dietary fat intakes. For the unadjusted cholesterol analysis, serum myristic acid and linoleic acid were regressed as continuous variables onto serum cholesterol concentrations.
For the adjusted analysis, the following potential confounding variables were included as covariates: age category (15-18, 19-24, 25-44, 45-64, and 65 y), sex, BMI category (,25, 25-29.9, and 30), ethnicity, smoking status, education category (no qualification, school qualification only or postschool qualification only, and school and postschool qualification), and family income category (loss/zero to $20,000, $20,001-$30,000, $30,001-$50,000, and .$50,000). We decided a priori to control for the interactions between sex and age category, sex and ethnicity, and sex and BMI category. Energy intake (kJ/d) was also included as a covariate in the dietary model. The unadjusted and adjusted mean values for saturated fat intake, dairy fat intake, and polyunsaturated fat intake, total cholesterol, and HDL cholesterol and the ratio of total to HDL cholesterol for each quintile of serum fatty acid in cholesterol ester and phospholipid were calculated with the use of linear prediction. Residuals were examined in all models. Survey-adjusted correlation coefficients for the relation between the serum fatty acids and dietary fat intake (as a percentage of total energy) were generated with the use of survey linear regression.
FATTY ACIDS PREDICT SERUM CHOLESTEROL
A bootstrapping sampling procedure, which involves the random selection with replacement of data values from the original data set, was used to generate 100 data sets of equal sample size to the original data set. For each data set, the adjusted b coefficients for the association between myristic acid and linoleic acid as molecular percentages or as concentrations and cholesterol concentrations were calculated. The percentage of bootstrapped data sets in which the adjusted b coefficients were positive was recorded for myristic and linoleic acid in serum cholesterol ester and phospholipid.
We tested for linear trends in serum cholesterol concentrations and dietary fat intake across the quintiles of serum myristate and linoleate by assigning the quintiles values of 0.00, 0.25, 0.50, 0.75, and 1.00 and modeling this as a continuous variable. All P values were 2-sided, and P , 0.05 was considered statistically significant.
RESULTS
Of the 3223 stored serum samples from the NNS97, the fatty acid composition of serum cholesterol ester and phospholipid was available for 2393 and 2416 participants, respectively. The fatty acid composition of 1 of these 2 serum lipid classes was analyzed for 2732 participants. There were statistically significant but minor differences in the distribution of sex, age, ethnicity, and BMI for participants in the NNS97 who had a fatty acid value for cholesterol ester or phospholipid (n = 2732) compared with participants who took part in the NNS97 but did not have a fatty acid measurement (n = 1904), as shown in Table 1 . There was no statistically significant evidence that the mean intake of saturated, dairy, and polyunsaturated fat and the concentrations of total and HDL cholesterol differed between these 2 groups.
Results for the mean fatty acid composition expressed as a molecular percentage and as a concentration for cholesterol ester and phospholipid are shown in Table 2 . Linoleic acid (18:2n26) accounted for nearly one-half (49.58%) of the molecular amount of all identified fatty acids in cholesterol ester and was also the major polyunsaturated fatty acid in phospholipid (19.01 molecular percentage). The relative percentage of myristic acid (14:0) was higher in cholesterol ester than in phospholipid, where it contributed 1.05% and 0.52% of the total molecular weight of fatty acids, respectively.
In general, both units of fatty acid measurement gave similar associations (P for trend) between serum myristic acid and linoleic acid and dietary fat intake ( Figure 1) . The statistical significance of the trends of association for the unadjusted and adjusted regression analyses differed little. After adjustment for potential confounders, serum myristic acid in cholesterol ester was positively associated with percentage energy from saturated fat and dairy fat and inversely associated with polyunsaturated fat intake. Serum linoleic acid in cholesterol ester and phospholipid was positively associated with polyunsaturated fat intake. Serum linoleic acid expressed as a molecular percentage in cholesterol ester was inversely associated with saturated fat. The difference in mean intake of saturated fat between the lowest and highest quintile of serum cholesteryl-myristate was 2.1% of energy for the molecular percentage and 1.3% of energy for the concentration; the corresponding differences in dairy fat intake were 4.1% of energy for the molecular percentage and 2.9% of energy for the concentration. Serum myristic acid in cholesterol ester, whether measured as molecular percentage or concentration, was significantly positively correlated with dietary saturated and dairy fat (Figure 1) . The same was true for myristic acid in phospholipid, with the exception that concentration was not significantly correlated with saturated fat intake. Serum linoleic acid, both as a molecular percentage and as a concentration, was significantly positively correlated with polyunsaturated fat intake.
The relation of serum myristic acid and linoleic acid with serum cholesterol concentrations after adjustment for potential confounders is shown in Figure 2 . Total cholesterol concentration increased significantly with increasing molecular percentage and concentration of myristic acid in cholesterol ester as well as phospholipid (P for all trends , 0.001). For the unadjusted analysis, when participants were ranked by molecular percentage of cholesteryl-myristate, mean total cholesterol concentration increased by 0.92 mmol/L between quintiles 1 and 5; the corresponding increase when ranked by the concentration of cholesteryl-myristate of serum cholesterol ester was 1.65 mmol/L (data not shown). After adjustment for potential confounders, mean total cholesterol concentration was 0.65 mmol/L higher in participants ranked in the fifth quintile of serum cholesterol ester myristic acid, expressed as a molecular percentage, compared with the first quintile. When serum cholesterol ester myristic acid was expressed as a concentration, mean total cholesterol concentration was 1.39 mmol/L higher in participants ranked in the fifth quintile than in those in the first quintile.
A higher molecular percentage of linoleic acid in both serum cholesterol ester and phospholipid was associated with lower serum total cholesterol concentrations. For the unadjusted analysis, serum total cholesterol was 0.38 mmol/L lower in quintile 5 than in quintile 1 when participants were ranked by serum cholesteryllinoleate and was 0.41 mmol/L lower when ranked by serum phospholipid-linoleate (P for both trends , 0.001; data not shown). After adjustment for confounders, serum total cholesterol was 0.18 mmol/L lower (P for trend: 0.027) in quintile 5 than in quintile 1 when participants were ranked by cholesteryl-linoleate, and was 0.20 mmol/L lower (P for trend: 0.027) when ranked by phospholipid-linoleate. In contrast to molecular percentage, a higher concentration of linoleic acid in serum cholesterol ester and in serum phospholipid was associated with higher concentrations of serum total cholesterol. For the unadjusted analysis, mean total cholesterol was 1.43 mmol/L higher in participants ranked in the highest compared with the lowest quintile of serum cholesteryl-linoleate and 1.18 mmol/L higher when ranked by serum phospholipid-linoleate (P for both trends , 0.001). After adjustment for confounders, mean total cholesterol was 1.09 mmol/L higher (P for trend , 0.001) in participants ranked in the highest compared with the lowest quintile of serum cholesteryl-linoleate concentration and 0.99 mmol/L higher (P for trend , 0.001) when ranked by serum phospholipid-linoleate. The concentration of every fatty acid in serum cholesterol ester and phospholipid was positively correlated with total cholesterol concentrations (range for cholesterol ester: r = 0.42-0.59, P , 0.001 for all; range for phospholipid: r = 0.16-0.56, P , 0.001 for all). Likewise, the total fatty acid concentration of serum cholesterol ester was also highly correlated with total cholesterol (r = 0.59, P , 0.001).
The molecular percentage of myristic and linoleic acids in serum cholesterol ester and phospholipid was not significantly associated with serum HDL-cholesterol concentrations. However, the concentration of myristic acid in serum phospholipid was positively associated with serum HDL cholesterol (Figure 2) .
The concentration of myristic and linoleic acids in serum cholesterol ester and phospholipid positively predicted the total: HDL-cholesterol ratio. When serum myristic acid and linoleic acid were expressed as molecular percentages, only myristic acid in cholesterol ester was significantly associated with the total: HDL-cholesterol ratio. Across the quintiles of cholesterylmyristate as molecular percentage and concentration, the ratio increased by 0.71 and 1.40, respectively (P for both trends , 0.001; Figure 2 ). FIGURE 1. Mean (6SEM) dietary fat (% energy) across quintiles of serum myristic and linoleic acids (n = 2732), expressed as molecular percentages and as concentrations (lmol/L). Survey regression was used to adjust the results for the potential confounders of sex, age category, ethnicity, BMI category, smoking status, education category, family income category, and energy intake and for the interactions of sex and age category, sex and ethnicity, and sex and BMI category.
1 P value for trend across quintiles. 2 Survey-adjusted correlation coefficient and corresponding P value for the relation between the serum fatty acid and dietary fat intake.
Results from the bootstrapping analysis (Figure 2 ) for the association of serum myristate and linoleate with the concentration of total and HDL cholesterol as well as the total:HDLcholesterol ratio show the percentage of bootstrapped sets in which the b coefficient was greater than zero. For both the concentration and the molecular percentage, 100% of the bootstrapped data sets had a positive value for the adjusted b coefficient from the regression of myristic acid onto total cholesterol concentrations. For the association between linoleic acid as a concentration and total cholesterol concentrations, all of the bootstrapped data sets had a positive value for the b coefficient. For linoleic acid as molecular percentage, only 1% of the phospholipid and cholesterol ester bootstrapped data sets had a positive value for the b coefficients for total cholesterol concentrations.
DISCUSSION
We have shown that serum myristic acid and linoleic acid predict the differential cholesterolemic effects of saturated and polyunsaturated fat intake only when expressed as molecular percentages, not as concentrations. When the unit of fatty acid measurement was molecular percentage, serum linoleic acid, whether in cholesterol ester or phospholipid, was inversely associated with serum total cholesterol concentrations. This is consistent with the proven cholesterol-lowering properties of dietary polyunsaturated fat (12, 13) , of which serum linoleic acid is a biomarker. The reason why serum myristic acid and linoleic acid as molecular percentages but not as concentrations predict the differential effects of dietary fat on blood cholesterol appears to be unrelated to their being superior biomarkers of dietary fat, because both units of fatty acid measurement showed similar associations with dietary fat intake. Thus, it appears that the relative amounts, rather than absolute concentrations, of serum myristic and linoleic acid reflect their metabolic influence on serum cholesterol.
The positive association between the concentration of linoleic acid in serum lipids and serum total cholesterol is opposite to the proven cholesterol-lowering effect of this fatty acid (12) (13) (14) 20) . The opposite direction of the association arises because across the full range of serum cholesterol concentrations, individuals with higher serum cholesterol concentrations have higher lipoprotein concentrations. Given that a large proportion of lipoproteins is composed of fatty acids, these individuals will have higher FIGURE 2. Mean (6SEM) serum cholesterol concentrations (mmol/L) across quintiles of serum myristic and linoleic acids (n = 2732), expressed as molecular percentages and as concentrations (lmol/L). Survey regression was used to adjust the results for the potential confounders of sex, age category, ethnicity, BMI category, smoking status, education category, and family income category and for the interactions of sex and age category, sex and ethnicity, and sex and BMI category. 1 P value for trend across quintiles. 2 Percentage of bootstrapped data sets for which the adjusted b coefficient was greater than zero.
concentrations of all serum fatty acids (1). Thus, it is not surprising that the concentration of every fatty acid in serum cholesterol ester and phospholipid was positively associated with total cholesterol concentrations. Schwertner and Mosser (21) concluded that serum fatty acids were more meaningful when reported as concentrations rather than as relative amounts (21) . Their conclusion was based on the differences in serum fatty acid concentrations between patients with and without heart disease that were much larger than the differences in the relative percentage of fatty acids. However, the larger differences in fatty acid concentrations were almost certainly a reflection of higher serum total cholesterol concentrations in those with heart disease. It is noteworthy that higher concentrations of linoleic acid in cholesterol ester and phospholipid predicted higher polyunsaturated fat intakes yet were not associated with lower serum total cholesterol concentration. These results show that the total amount of linoleic acid in serum has little direct influence on the metabolic pathways that determine serum cholesterol concentrations; rather, the metabolic link is through linoleic acid as a percentage of total serum fatty acids. Insofar as predictions of risk of disease, our results suggest that fatty acids expressed as molecular percentages may be better biomarkers for the metabolic effects of individual fatty acids. Given that the concentration of each serum fatty acid, not just myristic and linoleic acids, was positively correlated with serum total cholesterol, serum fatty acid concentrations are probably no more informative as biomarkers of disease risk than serum total cholesterol concentrations.
The concentration of myristic acid in serum phospholipid but not in cholesterol ester positively predicted serum HDL concentrations. The predominance of phospholipid over cholesterol esters in HDL may explain this finding (22) . Our results showed a positive association between the molecular percentage of myristic acid in cholesterol ester and the total:HDL-cholesterol ratio. However, this contrasts with results from a meta-analysis of trials of fat-modified diets and serum lipids, which showed that myristic acid did not alter the total:HDL-cholesterol ratio (12) . These contrasting results warrant investigation because the total: HDL-cholesterol ratio is more than twice as informative as total cholesterol in the prediction of risk of ischemic heart disease (23) .
In relation to biomarkers of dietary fat, the 2 units of fatty acid measurement gave very similar results. It is also noteworthy that for a given type of dietary fat, the magnitude of change in mean intake across the quintiles of serum cholesteryl-myristate differed little from phospholipid-myristate. Others have compared the strength of the association between dietary marine fats and serum n23 long-chain polyunsaturated fatty acids expressed as a concentration or as a relative percentage and have shown similar correlation coefficients for both units of measurements (24, 25) . Our results add to the current understanding by extending this association to myristic and linoleic acids as biomarkers of dietary saturated and polyunsaturated fat.
There were several limitations to the current study. The method of dietary assessment used in this large population sample was the 24-h recall, which does not give a reliable estimate of the habitual dietary fat intake of an individual, because of large day-to-day variation in nutrient intakes (26) . Participants in this study were not required to fast. On the individual level there may be a discrepancy between the fat composition of a recently ingested meal and habitual fat intake; however, on a population level, recently ingested meals will reflect usual intakes. Postprandial sampling would therefore affect the variability, rather than the mean estimates, of serum fatty acid composition. Had we used a method of dietary assessment that measured habitual intake and collected fasting samples, the associations we observed may have been stronger. The analytic measurement of serum fatty acid concentrations was less precise than that of molecular percentages; this difference in measurement error would have attenuated the association of serum fatty acid concentrations with dietary fat or serum cholesterol more than molecular percentage. In addition, when serum fatty acids are expressed as molecular percentages, an increase in one fatty acid that makes up a large percentage of the total will cause the relative contribution of other fatty acids to be lower, even when the absolute amount remains unaltered. However, our results clearly show that, regarding prediction of total cholesterol, it is the relative amount that is important.
Strengths of the current study, which add to the generalizability of the results, include the use of a population-based sampling frame and a large sample size, and good assessment of the exposure and outcome variables and potential confounders. It is useful to note that weight percentage is commonly used as a unit of measurement of fatty acids. In this regard, the regression of serum fatty acids, measured as molecular or weight percentage, on serum cholesterol and dietary fat will produce very similar results.
To the best of our knowledge, this study is the first to compare, in a population-based sample, the respective ability of serum myristic acid and linoleic acid in cholesterol ester and phospholipid, expressed as molecular percentages or as concentrations, to predict serum cholesterol concentrations and dietary fat intake. Our results suggest that, in terms of prediction of total cholesterol concentrations, it is the relative contribution of each fatty acid that is important rather than the absolute amount. Whether this preference for molecular percentage holds true for the prediction of the risk of chronic diseases such as cancer or other disease risk factors has not been explored but ought to be the subject of future investigations.
